Case Reports
doi: 10.1056/NEJMc1203770.
Central-airway necrosis after stereotactic body-radiation therapy
- PMID: 22694017
- DOI: 10.1056/NEJMc1203770
Item in Clipboard
Case Reports
Central-airway necrosis after stereotactic body-radiation therapy
N Engl J Med.
.
No abstract available
Similar articles
-
Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.Cancer Treat Rev. 2008 Dec;34(8):719-27. doi: 10.1016/j.ctrv.2008.06.001. Epub 2008 Jul 26. Cancer Treat Rev. 2008. PMID: 18657910 Review.
-
Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).J Thorac Cardiovasc Surg. 2010 Sep;140(3):583-9. doi: 10.1016/j.jtcvs.2010.01.046. Epub 2010 May 15. J Thorac Cardiovasc Surg. 2010. PMID: 20478576
-
Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):117-25. doi: 10.1016/j.ijrobp.2006.04.013. Epub 2006 Jun 9. Int J Radiat Oncol Biol Phys. 2006. PMID: 16765528
-
Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1283-6. doi: 10.1016/j.ijrobp.2008.08.036. Int J Radiat Oncol Biol Phys. 2008. PMID: 19028267
-
Stereotactic body radiation therapy for early-stage non-small-cell lung cancer.Expert Rev Anticancer Ther. 2008 Jan;8(1):87-98. doi: 10.1586/14737140.8.1.87. Expert Rev Anticancer Ther. 2008. PMID: 18095886 Review.
Cited by
-
Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy.Cancers (Basel). 2022 Nov 29;14(23):5908. doi: 10.3390/cancers14235908. Cancers (Basel). 2022. PMID: 36497390 Free PMC article.
-
Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702).Jpn J Clin Oncol. 2018 Dec 1;48(12):1076-1082. doi: 10.1093/jjco/hyy141. Jpn J Clin Oncol. 2018. PMID: 30277519 Free PMC article. Clinical Trial.
-
Retrospective analysis of stereotactic ablative radiotherapy (SABR) for metastatic lung lesions (MLLs) in comparison with a contemporaneous cohort of primary lung lesions (PLLs).J Thorac Dis. 2017 Mar;9(3):742-756. doi: 10.21037/jtd.2017.03.07. J Thorac Dis. 2017. PMID: 28449482 Free PMC article.
-
Cons: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?Transl Lung Cancer Res. 2015 Oct;4(5):623-6. doi: 10.3978/j.issn.2218-6751.2015.08.07. Transl Lung Cancer Res. 2015. PMID: 26629432 Free PMC article. No abstract available.
-
Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors.J Thorac Dis. 2020 Nov;12(11):7024-7031. doi: 10.21037/jtd-2019-cptn-01. J Thorac Dis. 2020. PMID: 33282407 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
